Fig. 2From: Soluble urokinase plasminogen activator receptor and lactate as prognostic biomarkers in patients presenting with non-specific chief complaints in the pre-hospital setting – the PRIUS-studyA: ROC curve based on suPAR and lactate by prevalent serious condition. B: ROC curve based on suPAR and lactate by 30-day mortalityBack to article page